Cargando…
Effects of food and alcohol on the pharmacokinetics of an oral, extended-release formulation of hydrocodone in healthy volunteers
BACKGROUND: The purpose of this study was to evaluate the pharmacokinetics, bioavailability, and safety of oral extended-release hydrocodone (HC-ER) when administered with food or alcohol. METHODS: Two single-center, open-label, randomized, crossover studies were conducted in healthy volunteers. In...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4307648/ https://www.ncbi.nlm.nih.gov/pubmed/25653563 http://dx.doi.org/10.2147/CPAA.S70831 |
Sumario: | BACKGROUND: The purpose of this study was to evaluate the pharmacokinetics, bioavailability, and safety of oral extended-release hydrocodone (HC-ER) when administered with food or alcohol. METHODS: Two single-center, open-label, randomized, crossover studies were conducted in healthy volunteers. In a two-period food-interaction study, 12 subjects received HC-ER 20 mg after an overnight fast and a high-fat meal. In a three-period alcohol-interaction study, 30 naltrexone-blocked subjects received HC-ER 50 mg with a 0%, 20%, or 40% alcohol/orange juice solution after an overnight fast. Pharmacokinetic parameters were derived from plasma concentrations of hydrocodone and its metabolites. RESULTS: Exposure to hydrocodone after HC-ER 20 mg was similar in the fed and fasted states, as assessed by area under the plasma concentration versus time curve from time of dosing to time of last detectable concentration (AUC(0–t); 316.14 versus 311.94 ng · h/mL); relative bioavailability (F(rel)) was 101.74%. Differences (fed versus fasted) in hydrocodone mean maximum plasma concentration (C(max); 28.86 versus 22.74 ng/mL) and median time to C(max) (t(max); 6 versus 8 hours) were not clinically significant. Administration of 20% alcohol with HC-ER 50 mg did not increase systemic exposure relative to 0% alcohol (AUC(0–t) 878 versus 832 ng · h/mL; F(rel) 105%) or result in clinically meaningful changes in C(max) (51.8 versus 46.3 ng/mL) or t(max) (5.44 versus 6.16 hours). Administration with 40% alcohol increased AUC(0–t) (1,008 ng · h/mL versus 832 ng · h/mL; F(rel) 120%) and C(max) (109 versus 46.3 ng/mL), and shortened t(max) (2.43 versus 6.16 hours). Adverse events occurred in 10.0%, 24.1%, and 66.7% of subjects after 0%, 20%, and 40% alcohol, respectively. CONCLUSION: HC-ER can be administered without regard to meals. While there was no evidence of “dose-dumping” (an unintended, rapid release in a short time period of all or most of the hydrocodone from HC-ER), even with 40% alcohol, as with all opioids, alcohol should not be ingested while using HC-ER. |
---|